Invatec launches the Maris Plus self-expanding peripheral stent system at CIRSE


Greater visibility and flexibility for the treatment of peripheral arterial disease in the iliac region.

Invatec has launched their latest self-expanding peripheral stent system, Maris Plus at CIRSE 2009. The Maris Plus stent has a “lesion-specific” design with larger sizes to meet the clinical requirements of the iliac region. The Maris Plus becomes the sixth stent platform now marketed by Invatec for the treatment of peripheral arterial disease, greatly optimising visibility, flexibility and ease of use for the physician, said a company press release.

“At Invatec, we pride ourselves on our ability to continually develop lesion specific solutions for cardiovascular arterial and venous disease. With the Maris Plus, we have created a novel, self-expanding stent platform specifically designed for the iliac artery,” said Stefan Widensohler and Andrea Venturelli, co-founders of Invatec. The Maris Plus is available in a 30–100mm length with 9–12mm diameter, meeting the variable needs of the iliac region. The distinct stent geometry allows for increased stability in the hip, yet it remains the most flexible stent on the market. Additionally, larger and fully integrated tantalum markers greatly enhance visibility for the physician.